Healthcare firm Abbott has expanded its electrophysiology portfolio in the US with the introduction of new EnSite Precision cardiac mapping system.
The company has also launched Advisor FL circular mapping catheter, Sensor Enabled to map cardiac arrhythmias during ablation treatments.
Cardiac mapping will enable to see an inside view of the heart, helping physicians to visualize and navigate cardiac anatomy to deliver precise ablation therapy.
Based on St. Jude Medical cardiac mapping technology, the next-generation EnSite Precision technology has been designed to offer automation, flexibility and precision in cardiac mapping during the treatment of patients with abnormal heart rhythms (cardiac arrhythmias).
EnSite Precision system will allow physicians to map heart chambers with any electrophysiology catheter and customize procedures to address the circumstances of each case.
The system features dual-technology platform that provides detailed anatomical models and maps to offer an effective treatment for a range of irregular heart rhythms such as atrial fibrillation or ventricular tachycardia.
It features EnSite automap module, which allows the electrophysiologist to rapidly carry out morphology matching to identify source of the irregular heartbeat.
EnSite automap includes new TurboMap feature that enables physician to quickly build a map of the heart.
Abbott electrophysiology business’ medical affairs vice president and medical director Dr Srijoy Mahapatra said: "This next generation technology was designed in collaboration with some of the world's leading electrophysiologists so that they can quickly and precisely identify the source and substrate source of a patient's irregular heartbeat.
"We expect the EnSite Precision cardiac mapping system to become the new standard for identifying abnormal heart rhythms when tailoring treatment for patients suffering from arrhythmias."
Image: Abbott’s EnSite Precision cardiac mapping system helps to create automated 3D maps of the heart. Photo: courtesy of Abbott.